Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 9,336 shares at $19.02 ($178K) on 2024-01-10, disclosed to the SEC on 2024-01-12.
Scheduled sale ($178k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.02 | 4,668 | $89K | 50.0% |
| 2 | $19.02 | 4,668 | $89K | 50.0% |
| Total | $19.02 avg | 9,336 | $178K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |